If you are looking to buy Tesamorelin 5mg research peptide in the UK only for a laboratory programme, this guide covers everything you need to make an informed sourcing and experimental design decision. Tesamorelin 5mg is the entry-format version of one of the most scientifically distinctive GHRH research compounds available, a full-length GHRH analogue with N-terminal stabilisation that gives it a unique receptor engagement profile no other GHRH research peptide can replicate.
This guide is written for two audiences: UK-based laboratory researchers and research professionals evaluating tesamorelin 5mg for their first research programme or a pilot investigation, and scientifically engaged individuals who want to understand what this compound is, how it works, and why the 5mg format is the appropriate entry point for initial research work with this GHRH analogue.
All content below relates strictly to laboratory research and scientific investigation. Ascend Peptides UK supplies tesamorelin 5mg as a high-purity research peptide for laboratory use only, not for human consumption, veterinary, or clinical application of any kind.
What Is Tesamorelin? Structure and Scientific Identity
Tesamorelin is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH), the endogenous hypothalamic peptide responsible for stimulating GH secretion from anterior pituitary somatotroph cells.
What makes Tesamorelin 5mg research peptide scientifically distinct from every other GHRH research compound available in the UK is a combination of two structural features that no other GHRH analogue shares simultaneously.
First, tesamorelin replicates the full 44-amino acid sequence of native GHRH, not a truncated version. Most other GHRH research peptides, including CJC-1295 without DAC and Sermorelin, are based on only the first 29 amino acids of the endogenous peptide.
The full-length sequence means tesamorelin engages the entire GHRH receptor binding interface, providing a receptor interaction profile that more closely reflects the endogenous ligand.
Second, tesamorelin carries a trans-3-hexenoic acid group covalently bonded to the N-terminal tyrosine residue. This modification is the source of its substantially improved resistance to DPP-IV (dipeptidyl aminopeptidase IV) enzymatic degradation, the primary enzyme responsible for the rapid breakdown of native GHRH in biological environments.
The result is a GHRH research compound that is designed to resist enzymatic degradation longer than native GHRH in laboratory conditions in research conditions than unmodified GHRH.
Tesamorelin 5mg Molecular Identity — Quick Reference
|
Identifier |
Value |
|---|---|
|
Scientific name |
Tesamorelin (INN) |
|
Type |
full-length 44-amino-acid GHRH analogue |
|
N-terminal modification |
Trans-3-hexenoic acid group on N-terminal tyrosine |
|
Molecular formula |
C221H366N72O67S |
|
Molecular weight |
~5,135.94 Da |
|
Receptor target |
GHRH receptor (GHRHR) — Gs-coupled GPCR |
|
Research category |
Growth Hormone Research Peptide |
|
Supplied form |
Lyophilised powder — white to off-white |
|
Format |
5mg per vial (also available: 10mg) |
|
Third-party testing |
Janoshik — HPLC + LC-MS verified |
Why Buy Tesamorelin 5mg Research Peptide? The Case for the Entry Format
Researchers looking to buy tesamorelin 5mg research peptide are typically at one of two stages in their programme: either beginning their first investigation with this GHRH analogue and wanting to validate methods before committing to larger quantities, or running smaller-scale studies where the compound volume requirements do not justify the 10mg format. Both are entirely valid scientific rationales for the 5mg format.
|
Consideration |
Tesamorelin 5mg |
Tesamorelin 10mg |
|---|---|---|
|
Best suited for |
Pilot studies, method development, preliminary investigations |
Established programmes, multi-arm studies, high-throughput assays |
|
Research stage |
Early-stage or first-time tesamorelin research |
Confirmed demand, ongoing programme |
|
Dose-response capability |
Limited concentration range |
Full concentration gradient studies |
|
Cost per milligram |
Higher per mg — smaller quantity |
Better value — larger quantity |
|
Batch consistency |
Single batch for pilot |
Extended single-batch use |
|
Aliquots possible |
Fewer single-use aliquots |
A greater number of aliquots |
|
Ideal researcher type |
First-time buyers, pilot-study users, small labs |
Active programmes, institutions, CROs |
|
Purity standard |
≥98% HPLC-verified |
≥98% HPLC-verified (identical standard) |
The most important practical advantage of starting with the tesamorelin 5mg research compound is risk management. When working with a GHRH analogue for the first time, establishing reconstitution protocols, validating assay conditions, and confirming that the compound behaves as expected in your specific cell model or experimental system, committing to the 10mg format before method validation is complete is unnecessary.
The 5mg format provides sufficient material to run pilot assays and generate preliminary data, after which the 10mg format becomes the appropriate choice for the full programme.
For researchers who have already validated their tesamorelin protocols and are ready for a larger programme, our dedicated tesamorelin 10mg research peptide guide covers the advanced format in full, including why single-batch consistency matters for established programmes and how the 10mg format supports high-throughput assay designs.
How Tesamorelin 5mg Works in Laboratory Research Models
Understanding the mechanism of the tesamorelin 5mg research peptide is essential for designing rigorous experimental protocols and interpreting results correctly. Tesamorelin acts as a selective agonist (preclinical and clinical research models) at the GHRH receptor (GHRHR), a Gs-coupled G-protein-coupled receptor expressed predominantly on anterior pituitary somatotroph cells.
GHRHR Signalling Cascade
When tesamorelin binds to GHRHR, it initiates the following signalling sequence in laboratory research models:
-
GHRHR activation → Gs protein stimulation → adenylyl cyclase activation → intracellular cAMP elevation
-
Elevated cAMP → protein kinase A (PKA) activation → downstream transcription factor phosphorylation
-
PKA activation → increased GH mRNA transcription → pulsatile growth hormone secretion from somatotroph cells
-
GH secretion → hepatic IGF-1 production → downstream growth factor signalling cascade
Because the tesamorelin 5mg research compound uses the full 44-amino acid GHRH sequence, it engages the complete GHRHR binding interface, a mechanistically important distinction from shorter GHRH analogues.
For researchers studying receptor structure-function relationships or designing experiments that require maximal and physiologically relevant GHRH receptor engagement, this full-length engagement profile is a significant experimental advantage.
Research Applications of Tesamorelin 5mg in Laboratory Settings
The tesamorelin 5mg research peptide is used across a range of scientific disciplines within the Growth Hormone Research Peptide category. The following research contexts represent the primary applications for which the compound has been studied in preclinical and clinical literature.
1. GH Axis Pilot Studies and Method Development
The 5mg format of tesamorelin research compound UK is particularly suited to pilot investigations of the GHRH-GH signalling axis.
Researchers establishing assay conditions, validating antibody-based GH detection methods, or testing dose-response parameters before committing to larger experimental series use the 5mg format to generate preliminary data efficiently without overcommitting compound volume.
2. GHRH Receptor Biology Research
Because tesamorelin is the only commercially available research-grade full-length GHRH analogue, it occupies a unique position in GHRH receptor studies.
Researchers investigating GHRHR binding kinetics, receptor conformational changes upon full-length ligand engagement, and how complete versus truncated GHRH sequences affect downstream signal transduction use this compound as an irreplaceable research tool.
The 5mg format is appropriate for receptor binding assays and preliminary receptor characterisation work.
3. Metabolic Pathway Research
Tesamorelin peptide for research has been studied in the context of metabolic biology, particularly the role of the GH-IGF-1 axis in lipid metabolism and adipose tissue biology at the cellular level.
Laboratory investigations using GHRH analogues to probe how upstream receptor activation influences downstream metabolic signalling pathways benefit from the 5mg format when the study design involves limited assay numbers or a specific cell line validation phase.
4. Comparative GHRH Analogue Studies
A productive line of laboratory research compares different GHRH analogues to understand how structural differences in truncated versus full-length sequence, different N-terminal modifications, and varying DPP-IV resistance profiles translate into measurable differences in receptor activation and GH secretion dynamics.
Buying Tesamorelin 5mg research peptide alongside CJC-1295 without DAC or Sermorelin enables researchers to run direct comparative assays from the same batch quantities without requiring large volumes of either compound.
5. GH-IGF-1 Axis Upstream Research
Researchers studying the GH-IGF-1 signalling cascade, one of the most studied axes in endocrine and metabolic biology, use GHRH analogues as upstream stimulants in experimental designs that also examine downstream IGF-1 production and receptor effects.
For the downstream component of this research axis, our IGF-1 LR3 1mg research guide provides a detailed scientific overview of how IGF-1 LR3 functions as a growth factor research tool in the downstream signalling pathway, a compound frequently studied in conjunction with GHRH analogues in multi-pathway GH axis research programmes.
Tesamorelin 5mg vs Other GHRH Research Peptides
Researchers evaluating the tesamorelin 5mg research compound UK, alongside other GHRH analogues, need a clear picture of how these peptides differ scientifically. The following comparison covers the three most commonly studied GHRH research peptides available from Ascend Peptides UK.
|
Property |
Tesamorelin 5mg/10mg |
CJC-1295 Without DAC |
Sermorelin |
|---|---|---|---|
|
Amino acid length |
44 (full-length GHRH) |
29 (truncated GHRH) |
29 (truncated GHRH) |
|
N-terminal modification |
Trans-3-hexenoic acid |
4 amino acid substitutions |
None |
|
DPP-IV resistance |
✓✓ High |
✓✓ High |
✓ Moderate |
|
GHRH receptor engagement |
Full 44-AA interface |
Partial (29-AA) |
Partial (29-AA) |
|
Research distinction |
Only full-length analogue |
Most widely studied |
Closest to native GHRH |
|
Format available |
5mg + 10mg |
10mg |
2mg + 5mg |
The most significant distinction for experimental design is the amino acid length. The tesamorelin 5mg research peptide uses all 44 amino acids of native GHRH, making it the only full-length GHRH analogue in the research category.
CJC-1295, without DAC and Sermorelin, uses only the first 29 amino acids. For a detailed comparison of CJC-1295 Without DAC, see our complete CJC-1295 Without DAC research guide, the most widely studied GHRH analogue in UK laboratory research and one that is frequently compared directly with tesamorelin in GHRH comparative studies.
Where to Buy Tesamorelin 5mg Research Peptide UK
When you buy Tesamorelin 5mg research peptide in the UK, the quality and analytical verification of the compound directly determine the reliability of your experimental data.
Research programmes built on sub-standard compounds produce unreliable results, and with a full-length GHRH analogue carrying an N-terminal modification, verification of both the complete peptide sequence and the intact modification is recommended.
When evaluating a tesamorelin 5mg supplier UK, these are the quality standards every researcher should confirm before purchasing:
-
HPLC purity verification: ≥98% purity confirmed by High-Performance Liquid Chromatography on a batch-specific basis
-
LC-MS identity confirmation: Molecular weight verified to match the expected full-length tesamorelin structure, including confirmation that the trans-3-hexenoic acid N-terminal modification is intact
-
Independent third-party testing: Certificate of Analysis from an external analytical laboratory, not in-house testing
-
Lyophilised format: Freeze-dried powder is the only format that maintains long-term stability for a peptide of this molecular complexity
-
Full batch traceability: Complete documentation for referencing in published research
-
Research-only labelling: No health, cosmetic, or clinical claims, clear research-use-only designation
-
UK-based supplier: Same-day dispatch, no international transit delays or stability risks
Ascend Peptides UK supplies Tesamorelin 5mg research compound UK to all of these standards. Every batch is independently tested by Janoshik, a specialist peptide analytical laboratory, with a publicly verifiable Certificate of Analysis available for every vial before dispatch. We are a UK-based tesamorelin 5mg supplier serving independent researchers, private laboratories, and research institutions across the United Kingdom.
Buy Tesamorelin 5mg research peptide directly from Ascend Peptides UK, or explore our complete range of growth hormone research peptides and scientific compounds — all dispatched same day for orders placed before 4 pm, with free shipping on orders over £50.
Storage and Reconstitution: Laboratory Reference
Tesamorelin 5mg is supplied as a lyophilised (freeze-dried) powder and must be reconstituted before use in laboratory assays. This section is provided as a reference for qualified research personnel working under appropriate institutional guidelines. Given the molecular complexity of tesamorelin, a full-length GHRH analogue with N-terminal modification, careful handling is especially important to preserve peptide structural integrity.
-
Storage before reconstitution: Store at -20°C for long-term stability. For short-term use, 2–8°C refrigeration is appropriate. Protect from direct light and moisture at all times.
-
Reconstitution solvent: Sterile bacteriostatic water is the most widely referenced solvent in published tesamorelin laboratory protocols, providing extended post-reconstitution stability.
-
Addition technique: Add solvent slowly down the inner wall of the vial. Do not inject directly onto the lyophilised powder with force this can damage the full-length peptide structure.
-
Dissolution: Gently swirl or roll the vial between your fingers until fully dissolved. Do not shake or vortex the tesamorelin 5mg research compound; vigorous agitation risks disrupting the N-terminal modification.
-
Aliquoting: Divide immediately into single-use aliquots upon reconstitution. Store all aliquots at -20°C.
-
Freeze-thaw cycles: Avoid for both the lyophilised powder and reconstituted solution. Every additional freeze-thaw cycle degrades peptide integrity and introduces experimental inconsistency.
Ascend Peptides UK supplies bacteriostatic water for research alongside tesamorelin 5mg, allowing researchers to source their GHRH analogue and reconstitution solvent from a single trusted UK supplier with same-day dispatch.
UK Regulatory Status and Research Compliance
Tesamorelin 5mg research peptide is classified as a research chemical in the United Kingdom. It is not a licensed general medicine, not approved for human consumption, and must not be used in any clinical, veterinary, or diagnostic context outside of properly regulated research frameworks.
Researchers should note that Tesamorelin has received regulatory approval in specific clinical formulations in other jurisdictions. The FDA approved Egrifta (tesamorelin for injection) for a specific clinical indication, and the EMA has reviewed the compound.
This clinical history provides researchers with access to a published pharmacokinetic and safety dataset that many synthetic research peptides lack. However, this clinical history does not extend any licensed status to the 5mg lyophilised research format, which is supplied strictly for laboratory investigation.
For any in vivo animal research conducted in the UK, full compliance with the Animals (Scientific Procedures) Act 1986 (ASPA) is mandatory, requiring valid Home Office licences and full institutional ethical approval before any experimental work begins. All buyers are responsible for ensuring their acquisition and use of Tesamorelin 5mg research compound UK complies with applicable UK legislation and institutional ethics requirements.
Why UK Researchers Choose Ascend Peptides UK for Tesamorelin 5mg
Ascend Peptides UK is a dedicated research peptides company built to serve the needs of UK laboratories, research institutions, and scientifically engaged individuals.
Our tesamorelin 5mg research peptide is one of over twenty independently verified research compounds available with same-day UK dispatch.
-
High-purity research peptides: Every batch is independently tested by Janoshik before dispatch verifiable CoA for every vial
-
UK-based tesamorelin 5mg supplier UK: Same-day dispatch for orders placed before 4 pm, no international transit delays
-
Both formats available: Tesamorelin 5mg for pilot work and method development; Tesamorelin 10mg for established programmes
-
Free shipping: On all orders over £50 across the United Kingdom
-
Complete Growth Hormone Peptide range: Tesamorelin, CJC-1295, Sermorelin, Ipamorelin, all independently tested
-
Research-only supply: No health, cosmetic, or clinical claims on any product
Conclusion: Buy Tesamorelin 5mg Research Peptide UK
The tesamorelin 5mg research peptide occupies a unique position within the UK GHRH research compound landscape it is the only full-length GHRH analogue available, combining the complete 44-amino acid GHRH sequence with N-terminal stabilisation that extends receptor activity in laboratory conditions.
For researchers beginning their first investigation with this compound, or running smaller-scale pilot studies that do not require the full 10mg volume, the 5mg format is the scientifically appropriate and cost-effective entry point.
For UK researchers and laboratories looking to buy tesamorelin 5mg research peptide from a reliable tesamorelin 5mg supplier UK, Ascend Peptides UK provides this compound to ≥98% HPLC-verified purity, independently tested by Janoshik, with a publicly verifiable Certificate of Analysis and same-day UK dispatch.
Buy Tesamorelin 5mg research peptide today at Ascend Peptides UK.
Frequently Asked Questions
Q: Where can I buy Tesamorelin 5mg research peptide in the UK?
A: Tesamorelin 5mg research peptide is available to buy directly from Ascend Peptides UK a UK-based tesamorelin 5mg supplier with same-day dispatch for orders placed before 4 pm. Every vial is independently tested by Janoshik with a publicly verifiable Certificate of Analysis. Free shipping on orders over £50. All products are for laboratory research use only.
Q: What is the tesamorelin 5mg research peptide used for?
A: The tesamorelin 5mg research peptide is used in laboratory settings to study GHRH receptor biology, the hypothalamic-pituitary-somatotropic axis, GH secretion dynamics, metabolic pathway research via the GH-IGF-1 signalling cascade, and comparative GHRH analogue pharmacology. The 5mg format is particularly suited to pilot studies, method development, and preliminary investigations before committing to the larger 10mg format.
Q: What is the difference between tesamorelin 5mg and tesamorelin 10mg?
A: The compound is identical in both formats — the difference is quantity and the scale of the research programme each format supports. Tesamorelin 5mg is the appropriate choice for pilot studies, method development, first-time research with this compound, or smaller-scale assays. Tesamorelin 10mg is the appropriate choice for established programmes requiring multi-arm studies, full dose-response concentration ranges, or extended single-batch consistency. Both are available from Ascend Peptides UK to ≥98% HPLC-verified purity.
Q: What makes Tesamorelin 5mg different from CJC-1295 and Sermorelin?
A: Tesamorelin is the only full-length GHRH analogue in the research category — it replicates all 44 amino acids of native GHRH, modified with a trans-3-hexenoic acid group for N-terminal stability. CJC-1295, without DAC and Sermorelin, are both based on only the first 29 amino acids of GHRH. The full-length sequence gives tesamorelin a more complete GHRH receptor engagement profile in laboratory models, making it the appropriate choice for research requiring physiological relevance or receptor structure-function studies.
Q: Is Tesamorelin 5mg research peptide legal in the UK?
A: Yes. Tesamorelin 5mg research peptide is legal to purchase in the United Kingdom as a research chemical for legitimate scientific and laboratory use. It is not classified as a controlled substance under UK law. However, it is not approved for human consumption or general clinical use in the UK and must not be used outside of properly regulated research frameworks. All buyers are responsible for ensuring compliance with applicable regulations.
Q: How should Tesamorelin 5mg be stored?
A: Lyophilised tesamorelin 5mg should be stored at -20°C for long-term stability, or at 2–8°C for short-term use. Protect from direct light and moisture. Once reconstituted, aliquot immediately into single-use volumes and store at -20°C. Avoid repeated freeze-thaw cycles for both the lyophilised powder and reconstituted solution — vigorous agitation during reconstitution should also be avoided to preserve the N-terminal modification.
Q: What reconstitution solvent should I use for tesamorelin 5mg?
A: Sterile bacteriostatic water is the most widely referenced solvent for tesamorelin reconstitution in published laboratory protocols. Add the solvent slowly down the inner wall of the vial and gently swirl to dissolve — do not shake or vortex. Aliquot immediately and store at -20°C. Ascend Peptides UK supplies bacteriostatic water for research alongside tesamorelin 5mg, allowing both to be sourced from a single UK supplier.
Q: What purity standard should Tesamorelin 5mg meet for research use?
A: Research-grade tesamorelin 5mg should be at least 98% pure, confirmed by HPLC analysis. Critically for a compound with an N-terminal modification, molecular identity — including confirmation that the trans-3-hexenoic acid group is intact — must be verified by LC-MS. A batch-specific Certificate of Analysis from an independent third-party laboratory is essential. Ascend Peptides UK tests every batch through Janoshik with publicly verifiable documentation.
Q: What is the tesamorelin 5mg price in the UK?
A: Tesamorelin 5mg research peptide is available from Ascend Peptides UK with competitive UK pricing. Free shipping applies to all orders over £50, and bacteriostatic water is included free with orders over £75. Visit the Ascend Peptides UK product page for current pricing and availability. All products are supplied for laboratory research use only.
Q: Can tesamorelin 5mg be used for GHRH receptor research?
A: Yes. The tesamorelin 5mg research compound is particularly well-suited to GHRH receptor biology studies precisely because it is the only commercially available full-length GHRH analogue. Its complete 44-amino acid sequence engages the full GHRHR binding interface, making it the most appropriate molecular tool for research examining receptor structure-function relationships, binding kinetics, and how complete versus truncated GHRH sequences affect receptor activation and downstream signal transduction.
DISCLAIMER
All products supplied by Ascend Peptides UK are intended strictly for research purposes only. They are not intended for human consumption or for any therapeutic, diagnostic, or clinical use. None of the items offered are classified as medicinal products by the MHRA. It is the buyer’s responsibility to ensure all purchases comply with applicable laws and regulations. Ascend Peptides UK accepts no liability for misuse.
